• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CSL 2.48% $277.01

CSL LIMITED - Announcements

CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus... CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The Company operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

CSL Daily share buy-back notice - Appendix 3E11/11/15
CSL Daily share buy-back notice - Appendix 3E06/11/15
CSL Daily share buy-back notice - Appendix 3E03/11/15
CSL Daily share buy-back notice - Appendix 3E03/11/15
CSL Daily share buy-back notice - Appendix 3E02/11/15
CSL Changes relating to buy-back - Appendix 3D27/10/15
CSL Appendix 3B26/10/15
CSL Change of Director's Interest Notice26/10/15
CSL Appendix 3Y Change of Directors Interest Notice23/10/15
CSL Results of Meeting15/10/15
CSL Announcement of buy-back - Appendix 3CPRICE SENSITIVE15/10/15
CSL Chairman's Address to Shareholders15/10/15
CSL CSL Names New Chief Finance Officer09/10/15
CSL New US Private PlacementPRICE SENSITIVE09/10/15
CSL Appendix 3B07/10/15
CSL Appendix 3B15/09/15
CSL Appendix 4G Corporate Governance Key Disclosures11/09/15
CSL Notice of Annual General Meeting/Proxy Form/Questionnaire11/09/15
CSL Annual Report to shareholders11/09/15
CSL Appendix 3B25/08/15
CSL Change of Director's Interest Notice21/08/15
CSL Change of Director's Interest Notice21/08/15
CSL Dividend/Distribution - CSL12/08/15
CSL FY2015 Results Announcement and Analysts PresentationPRICE SENSITIVE12/08/15
CSL Appendix 4E Directors Report and Financial StatementsPRICE SENSITIVE12/08/15
CSL Notice of Investor/Analyst Briefing - 2015 Full Year Result11/08/15
CSL Change to Company Details06/08/15
CSL Appendix 3B Amendment05/08/15
CSL Appendix 3B04/08/15
CSL Completes Novartis Influenza Vaccine Business Acquisition03/08/15
CSL Update on Novartis Influenza Vaccine AcquisitionPRICE SENSITIVE31/07/15
CSL US FDA Accepts for Review rFVIII BLAPRICE SENSITIVE28/07/15
CSL Change to Company Details21/07/15
CSL Appendix 3B14/07/15
CSL Change to Company Details26/06/15
CSL Appendix 3B23/06/15
CSL CSL Behring to Present Pivotal DataPRICE SENSITIVE17/06/15
CSL Final share buy-back notice - Appendix 3F12/06/15
CSL Daily share buy-back notice - Appendix 3E12/06/15
CSL Daily share buy-back notice - Appendix 3E11/06/15
CSL Daily share buy-back notice - Appendix 3E10/06/15
CSL Daily share buy-back notice - Appendix 3E05/06/15
CSL Changes to Company Details05/06/15
CSL Daily share buy-back notice - Appendix 3E04/06/15
CSL Appendix 3B02/06/15
CSL CSL Limited Financial Reporting Simplification02/06/15
CSL Daily share buy-back notice - Appendix 3E29/05/15
CSL Daily share buy-back notice - Appendix 3E28/05/15
CSL Daily share buy-back notice - Appendix 3E27/05/15
CSL Change of Company Details15/05/15
CSL Daily share buy-back notice - Appendix 3E15/05/15
CSL Daily share buy-back notice - Appendix 3E13/05/15
CSL Appendix 3B12/05/15
CSL Daily share buy-back notice - Appendix 3E12/05/15
CSL Daily share buy-back notice - Appendix 3E11/05/15
CSL Daily share buy-back notice - Appendix 3E07/05/15
CSL Daily share buy-back notice - Appendix 3E06/05/15
CSL Daily share buy-back notice - Appendix 3E04/05/15
CSL Daily share buy-back notice - Appendix 3E01/05/15
CSL Daily share buy-back notice - Appendix 3E30/04/15
CSL Daily share buy-back notice - Appendix 3E29/04/15
CSL Daily share buy-back notice - Appendix 3E24/04/15
CSL Change to Company Details24/04/15
CSL G. Naylor to Lead New Influenza Vaccine Business23/04/15
CSL Appendix 3B21/04/15
CSL Changes relating to buy-back - Appendix 3D21/04/15
CSL Daily share buy-back notice - Appendix 3E21/04/15
CSL Daily share buy-back notice - Appendix 3E20/04/15
CSL Daily share buy-back notice - Appendix 3E17/04/15
CSL Daily share buy-back notice - Appendix 3E16/04/15
CSL Daily share buy-back notice - Appendix 3E15/04/15
CSL Daily share buy-back notice - Appendix 3E13/04/15
CSL CSL Half Year Report Booklet10/04/15
CSL Change to Company Details07/04/15
CSL Daily share buy-back notice - Appendix 3E01/04/15
CSL Appendix 3B31/03/15
CSL Daily share buy-back notice - Appendix 3E31/03/15
CSL Daily share buy-back notice - Appendix 3E30/03/15
CSL Daily share buy-back notice - Appendix 3E27/03/15
CSL Daily share buy-back notice - Appendix 3E26/03/15
CSL Daily share buy-back notice - Appendix 3E19/03/15
CSL Daily share buy-back notice - Appendix 3E17/03/15
CSL Daily share buy-back notice - Appendix 3E16/03/15
CSL Change to Company Details13/03/15
CSL Daily share buy-back notice - Appendix 3E13/03/15
CSL Daily share buy-back notice - Appendix 3E12/03/15
CSL Appendix 3B10/03/15
CSL Daily share buy-back notice - Appendix 3E10/03/15
CSL Daily share buy-back notice - Appendix 3E06/03/15
CSL Daily share buy-back notice - Appendix 3E05/03/15
CSL Daily share buy-back notice - Appendix 3E04/03/15
CSL Daily share buy-back notice - Appendix 3E03/03/15
CSL Daily share buy-back notice - Appendix 3E27/02/15
CSL Daily share buy-back notice - Appendix 3E26/02/15
CSL Changes relating to buy-back - Appendix 3D25/02/15
CSL Daily share buy-back notice - Appendix 3E25/02/15
CSL Daily share buy-back notice - Appendix 3E24/02/15
CSL Daily share buy-back notice - Appendix 3E23/02/15
CSL Change of Director's Interest Notice20/02/15
CSL Daily share buy-back notice - Appendix 3E20/02/15
CSL Daily share buy-back notice - Appendix 3E
11/11/15
CSL Daily share buy-back notice - Appendix 3E
06/11/15
CSL Daily share buy-back notice - Appendix 3E
03/11/15
CSL Daily share buy-back notice - Appendix 3E
03/11/15
CSL Daily share buy-back notice - Appendix 3E
02/11/15
CSL Changes relating to buy-back - Appendix 3D
27/10/15
CSL Appendix 3B
26/10/15
CSL Change of Director's Interest Notice
26/10/15
CSL Appendix 3Y Change of Directors Interest Notice
23/10/15
CSL Results of Meeting
15/10/15
CSL Announcement of buy-back - Appendix 3C
15/10/15PRICE SENSITIVE
CSL Chairman's Address to Shareholders
15/10/15
CSL CSL Names New Chief Finance Officer
09/10/15
CSL New US Private Placement
09/10/15PRICE SENSITIVE
CSL Appendix 3B
07/10/15
CSL Appendix 3B
15/09/15
CSL Appendix 4G Corporate Governance Key Disclosures
11/09/15
CSL Notice of Annual General Meeting/Proxy Form/Questionnaire
11/09/15
CSL Annual Report to shareholders
11/09/15
CSL Appendix 3B
25/08/15
CSL Change of Director's Interest Notice
21/08/15
CSL Change of Director's Interest Notice
21/08/15
CSL Dividend/Distribution - CSL
12/08/15
CSL FY2015 Results Announcement and Analysts Presentation
12/08/15PRICE SENSITIVE
CSL Appendix 4E Directors Report and Financial Statements
12/08/15PRICE SENSITIVE
CSL Notice of Investor/Analyst Briefing - 2015 Full Year Result
11/08/15
CSL Change to Company Details
06/08/15
CSL Appendix 3B Amendment
05/08/15
CSL Appendix 3B
04/08/15
CSL Completes Novartis Influenza Vaccine Business Acquisition
03/08/15
CSL Update on Novartis Influenza Vaccine Acquisition
31/07/15PRICE SENSITIVE
CSL US FDA Accepts for Review rFVIII BLA
28/07/15PRICE SENSITIVE
CSL Change to Company Details
21/07/15
CSL Appendix 3B
14/07/15
CSL Change to Company Details
26/06/15
CSL Appendix 3B
23/06/15
CSL CSL Behring to Present Pivotal Data
17/06/15PRICE SENSITIVE
CSL Final share buy-back notice - Appendix 3F
12/06/15
CSL Daily share buy-back notice - Appendix 3E
12/06/15
CSL Daily share buy-back notice - Appendix 3E
11/06/15
CSL Daily share buy-back notice - Appendix 3E
10/06/15
CSL Daily share buy-back notice - Appendix 3E
05/06/15
CSL Changes to Company Details
05/06/15
CSL Daily share buy-back notice - Appendix 3E
04/06/15
CSL Appendix 3B
02/06/15
CSL CSL Limited Financial Reporting Simplification
02/06/15
CSL Daily share buy-back notice - Appendix 3E
29/05/15
CSL Daily share buy-back notice - Appendix 3E
28/05/15
CSL Daily share buy-back notice - Appendix 3E
27/05/15
CSL Change of Company Details
15/05/15
CSL Daily share buy-back notice - Appendix 3E
15/05/15
CSL Daily share buy-back notice - Appendix 3E
13/05/15
CSL Appendix 3B
12/05/15
CSL Daily share buy-back notice - Appendix 3E
12/05/15
CSL Daily share buy-back notice - Appendix 3E
11/05/15
CSL Daily share buy-back notice - Appendix 3E
07/05/15
CSL Daily share buy-back notice - Appendix 3E
06/05/15
CSL Daily share buy-back notice - Appendix 3E
04/05/15
CSL Daily share buy-back notice - Appendix 3E
01/05/15
CSL Daily share buy-back notice - Appendix 3E
30/04/15
CSL Daily share buy-back notice - Appendix 3E
29/04/15
CSL Daily share buy-back notice - Appendix 3E
24/04/15
CSL Change to Company Details
24/04/15
CSL G. Naylor to Lead New Influenza Vaccine Business
23/04/15
CSL Appendix 3B
21/04/15
CSL Changes relating to buy-back - Appendix 3D
21/04/15
CSL Daily share buy-back notice - Appendix 3E
21/04/15
CSL Daily share buy-back notice - Appendix 3E
20/04/15
CSL Daily share buy-back notice - Appendix 3E
17/04/15
CSL Daily share buy-back notice - Appendix 3E
16/04/15
CSL Daily share buy-back notice - Appendix 3E
15/04/15
CSL Daily share buy-back notice - Appendix 3E
13/04/15
CSL CSL Half Year Report Booklet
10/04/15
CSL Change to Company Details
07/04/15
CSL Daily share buy-back notice - Appendix 3E
01/04/15
CSL Appendix 3B
31/03/15
CSL Daily share buy-back notice - Appendix 3E
31/03/15
CSL Daily share buy-back notice - Appendix 3E
30/03/15
CSL Daily share buy-back notice - Appendix 3E
27/03/15
CSL Daily share buy-back notice - Appendix 3E
26/03/15
CSL Daily share buy-back notice - Appendix 3E
19/03/15
CSL Daily share buy-back notice - Appendix 3E
17/03/15
CSL Daily share buy-back notice - Appendix 3E
16/03/15
CSL Change to Company Details
13/03/15
CSL Daily share buy-back notice - Appendix 3E
13/03/15
CSL Daily share buy-back notice - Appendix 3E
12/03/15
CSL Appendix 3B
10/03/15
CSL Daily share buy-back notice - Appendix 3E
10/03/15
CSL Daily share buy-back notice - Appendix 3E
06/03/15
CSL Daily share buy-back notice - Appendix 3E
05/03/15
CSL Daily share buy-back notice - Appendix 3E
04/03/15
CSL Daily share buy-back notice - Appendix 3E
03/03/15
CSL Daily share buy-back notice - Appendix 3E
27/02/15
CSL Daily share buy-back notice - Appendix 3E
26/02/15
CSL Changes relating to buy-back - Appendix 3D
25/02/15
CSL Daily share buy-back notice - Appendix 3E
25/02/15
CSL Daily share buy-back notice - Appendix 3E
24/02/15
CSL Daily share buy-back notice - Appendix 3E
23/02/15
CSL Change of Director's Interest Notice
20/02/15
CSL Daily share buy-back notice - Appendix 3E
20/02/15
(20min delay)
Last
$277.01
Change
-7.040(2.48%)
Mkt cap ! $142.5B
Open High Low Value Volume
$280.67 $281.07 $275.01 $254.8M 915.5K

Buyers (Bids)

No. Vol. Price($)
13 1140 $277.00
 

Sellers (Offers)

Price($) Vol. No.
$277.08 312 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
Last
$277.26
  Change
-7.040 ( 2.70 %)
Open High Low Volume
$280.95 $280.98 $275.02 88510
Last updated 15.59pm 15/11/2024 ?
CSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.